عنوان

Behavioral neurobiology of psychedelic drugs /

شابک

3662558793

شابک

3662558807

شابک

3662585634

شابک

9783662558799

شابک

9783662558805

شابک

9783662585634

شابک اشتباه

3662558785

شابک اشتباه

9783662558782

عنوان اصلي

Behavioral neurobiology of psychedelic drugs /

نام عام مواد

[Book]

نام نخستين پديدآور

Adam L. Halberstadt, Franz X. Vollenweider, David E. Nichols, editors.

محل نشرو پخش و غیره

Berlin, Germany :

نام ناشر، پخش کننده و غيره

Springer,

تاریخ نشرو بخش و غیره

2018.

نام خاص و کميت اثر

1 online resource (x, 430 pages) :

ساير جزييات

illustrations (some color)

عنوان فروست

Current topics in behavioral neurosciences,

مشخصه جلد

volume 36

شاپا ي ISSN فروست

1866-3370 ;

متن يادداشت

Intro; Preface; References; Contents; 475 Chemistry and Structure-Activity Relationships of Psychedelics; Abstract; 1 Introduction; 2 Tryptamines; 2.1 Ring Substituents; 2.2 N-Alkylation; 2.3 Side Chain Alkylation; 3 Ergolines; 3.1 Amide Modifications of Lysergic Acid Derivatives; 3.2 N(6)-Alkyl Modifications of LSD; 4 Ergolines as "Research Chemicals"; 5 Phenethylamines and Related Congeners; 5.1 Beta-Oxygenated Phenethylamines; 5.2 Ring Substituents; 5.3 Methoxy Mimics-Benzofuran and Benzopyran Analogues; 5.4 Effect of Side Chain Alpha-Alkylation.

متن يادداشت

2 Clinical Relevance of the Interactions Between Glutamate and 5-HT2A Receptors in the mPFC3 Conclusions; References; 479 The Effects of Hallucinogens on Gene Expression; Abstract; 1 Introduction; 2 Immediate Early Genes; 3 IEG and 5-HT2A Receptor Expression: Early Studies; 4 Identification of Tissues that Transcriptionally Respond to Psychedelics: Early Studies; 5 IEG and 5-HT2A Receptor Expression in the Post-Genomic Era; 6 Psychedelics, Gene Expression, and Cellular Signaling; 7 Identification and Characterization of the Cortical Cellular Population Responsive to Psychedelics.

متن يادداشت

4 Role of Thalamocortical Inputs5 Brain Oscillations: Relevance to Schizophrenia; 6 Effects of Psychotomimetic Agents on Low Frequency Cortical Oscillations; 7 Mechanisms Involved in the Reversal by Antipsychotic Drugs; 8 Concluding Remarks; Acknowledgements; References; 480 Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons; Abstract; 1 From 5-HT2A Receptor-Induced EPSCs and Recurrent Neuronal Activity to Salient Behavioral Effects Induced by 5-HT2A Receptor Activation.

متن يادداشت

5 Biased Agonism at the 5-HT2A Receptor6 Additional Signaling Pathways Modulated by Activation of the 5-HT2A Receptor; 7 Role of mGlu2 Receptor in Hallucinogen Action; 8 Future Directions; Acknowledgements; References; 473 Effects of Hallucinogens on Neuronal Activity; Abstract; 1 Hallucinogens as Pharmacological Models in Schizophrenia Research; 1.1 Serotonergic Hallucinogens; 1.2 NMDA Receptors. Noncompetitive Antagonists; 2 The Prefrontal Cortex; 3 Effects of Psychotomimetic Agents on Neuronal Activity in PFC; 3.1 Serotonergic Hallucinogens; 3.2 Noncompetitive NMDA Receptor Antagonists.

متن يادداشت

6 Identifying the "Active" Conformation of the Phenethylamines6.1 Effect of an N-Benzyl Group; 6.2 The Active Conformation of N-Benzylphenethylamines; 7 Modeling the Receptor-Ligand Interaction; 8 Conclusion; References; 478 Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways; Abstract; 1 Introduction to Receptor Pharmacology; 2 Serotonin and Serotonin Receptors: A Historical Perspective; 2.1 Serotonin; 2.2 Serotonin Receptors; 3 Chemical Neuroanatomy of 5-HT2A Receptors; 4 Hallucinogenic and Non-Hallucinogenic 5-HT2A Receptor Agonists.

بدون عنوان

0

بدون عنوان

8

بدون عنوان

8

بدون عنوان

8

بدون عنوان

8

متن يادداشت

This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.

شماره استاندارد بين المللي کتاب و موسيقي

9783662558782

موضوع مستند نشده

Clinical neuropsychology.

موضوع مستند نشده

Hallucinogenic drugs.

موضوع مستند نشده

Neurobiology.

موضوع مستند نشده

Brain-- drug effects.

موضوع مستند نشده

Delusions-- chemically induced.

موضوع مستند نشده

Hallucinogens.

موضوع مستند نشده

Neurobehavioral Manifestations-- drug effects.

موضوع مستند نشده

Clinical neuropsychology.

موضوع مستند نشده

Hallucinogenic drugs.

موضوع مستند نشده

MEDICAL-- Pharmacology.

موضوع مستند نشده

Neurobiology.

موضوع مستند نشده

MED-- 071000

موضوع مستند نشده

PSAN

موضوع مستند نشده

PSAN

شماره

ويراست

شماره رده

شماره رده

مستند نام اشخاص تاييد نشده

Halberstadt, Adam L.

مستند نام اشخاص تاييد نشده

Nichols, David E.,1944-

مستند نام اشخاص تاييد نشده

Vollenweider, Franz X.

تاريخ عمليات

20200823190838.0

قواعد فهرست نويسي ( بخش توصيفي )

pn

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y